CYANOCOBALAMIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 22 adverse event reports in the FDA FAERS database where CYANOCOBALAMIN was used for Psoriasis.
Most Reported Side Effects for CYANOCOBALAMIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Gastrooesophageal reflux disease | 631 | 15.5% | 26 | 526 |
| Drug ineffective | 596 | 14.7% | 101 | 331 |
| Hypertension | 530 | 13.1% | 134 | 436 |
| Asthma | 525 | 12.9% | 32 | 399 |
| Headache | 523 | 12.9% | 64 | 346 |
| Dyspnoea | 511 | 12.6% | 43 | 344 |
| Wheezing | 467 | 11.5% | 101 | 356 |
| Fatigue | 458 | 11.3% | 117 | 270 |
| Therapeutic product effect incomplete | 426 | 10.5% | 29 | 324 |
| Fibromyalgia | 374 | 9.2% | 119 | 332 |
| Sleep disorder due to a general medical condition | 365 | 9.0% | 17 | 245 |
| Off label use | 351 | 8.6% | 127 | 217 |
| Pyrexia | 339 | 8.4% | 117 | 261 |
| Vomiting | 339 | 8.4% | 138 | 233 |
| Loss of personal independence in daily activities | 333 | 8.2% | 11 | 222 |
Other Indications for CYANOCOBALAMIN
Product used for unknown indication (2,695)
Vitamin b12 deficiency (179)
Vitamin supplementation (79)
Supplementation therapy (75)
Rheumatoid arthritis (46)
Vitamin b12 decreased (39)
Foetal exposure during pregnancy (27)
Pernicious anaemia (27)
Nutritional supplementation (24)
Anaemia (22)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)